Bio-engineered Stent Market Key Players | Medtronic,., Boston Scientific Corporation, Abbott Laboratories

The global Bio-engineered Stent market was valued at $2,764.2 Mn in 2020 and is expected to reach $5,841.8 Mn by 2028 growing at a CAGR of 8.7% over the forecast period 2021-2028.

Bio-engineered stents consist of short narrow metal or plastic tube, which is used to treat blocked arteries. It is used by patients who are suffering from different types of cardiovascular diseases such as coronary heart disease and ischemic heart disease. Different types of bio-engineered stent are available in market for various diseases such as coronary artery disease, peripheral arterial disease, carotid artery disease, renal artery stenosis, abdominal aortic aneurysm, thoracic aortic aneurysm among others.

Some of the key players profiled in this report are Medtronic, plc., Boston Scientific Corporation, Abbott Laboratories, Braun Melsungen AG, Terumo Corporation, MicroPort Scientific Corporation, Stentys Sao, Meril Life Sciences Pvt. Ltd, Vascular Concepts, W. L. Gore and Associates, C. R. Bard, Endologix, Inc., Lombard Medical Technologies, Translumina GmbH, and JOTEC GmbH.

Get Sample PDF Brochure :
https://www.coherentmarketinsights.com/insight/request-sample/2484

KEY BENEFITS

• The in-depth analysis provides market intelligence with respect to segments based on types, applications and geographies to enable precise decision making

• The detailed analysis of the impact of top factors impacting the growth of the market for the short and medium term

• Value chain analysis provides key inputs on the role of all stakeholders of the market

• Porter’s five force analysis provides the potency of suppliers & buyers, threat of new entrants & substitutes along with competitive scenario of the market

• SWOT analysis and recent developments of key players are included in the report so that companies can understand the strategies adopted by competitors and make required changes to their plans

• Estimations are calculated according to the current market scenario and projected future trends for the analysis period of 2021-2028

• The report discusses the trends and opportunities in various geographies so that companies can make region specific plans to gain competitive advantage

KEY MARKETS SEGMENTS

By Application Type:
Coronary artery disease
Peripheral arterial disease
Carotid Artery Disease
Renal Artery Stenosis
Abdominal Aortic Aneurysm
Thoracic Aortic Aneurysm
Others

By Product Type:
Drug-eluting Stents
Bioabsorbable Stents
Drug-eluting Balloons

By Mode of Delivery:
Balloon-expandable Stents
Self-expanding Stents

By Material Type:
Metal-based
Polymer-based

By End User:
Hospitals & Cardiac Centers
Ambulatory Surgical Centers
Others

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

About Coherent Market Insights :

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

This release was published on openPR.